Pharma major’s 284 bps EBITDA margin gain and Unichem turnaround strategy draw bullish analyst calls  IPCA Laboratories has emerged as a growth story in India’s pharmaceutical sector with two leading brokerages issuing buy recommendations following the company’s third-quarter performance that showcased margin expansion even as revenue growth remained modest. TheContinue Reading